サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1791473

抗コクシジウム薬の世界市場

Anticoccidial Drugs

出版日
ページ情報
英文 162 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.73円
抗コクシジウム薬の世界市場
出版日: 2025年08月15日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 162 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

抗コクシジウム薬の世界市場は2030年までに2億5,460万米ドルに達する見込み

2024年に2億310万米ドルと推定される抗コクシジウム薬の世界市場は、分析期間2024-2030年にCAGR 3.8%で成長し、2030年には2億5,460万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである合成医薬品は、CAGR 4.5%を記録し、分析期間終了時には1億4,810万米ドルに達すると予測されます。イオノフォア医薬品セグメントの成長率は、分析期間中CAGR 2.9%と推定されます。

米国市場は5,340万米ドルと推定され、中国はCAGR 3.8％で成長すると予測される

米国の抗コクシジウム薬市場は2024年に5,340万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを3.8%として、2030年までに4,110万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.6％と3.3％と予測されています。欧州では、ドイツがCAGR 3.1%で成長すると予測されています。

世界の抗コクシジウム薬市場- 主要動向と促進要因まとめ

世界の抗コクシジウム薬需要を促進しているのは？

コクシジウム症は、家畜、特に家禽や牛にとって依然として根強い脅威であり、罹患率、死亡率、生産性の低下により大きな経済的損失をもたらしています。鶏肉や卵のようなタンパク質が豊富な食品に対する世界の需要の高まりは、効果的な抗コクシジウム薬の必要性を高めています。大規模な養鶏経営では、牛群の健康を維持し、アウトブレイクを予防するために、予防的および治療的抗コクシジウム剤に大きく依存しています。さらに、従来の治療法に対して耐性を示すEimeria寄生虫の新種が出現しているため、有効性が強化され、耐性プロファイルが低減された新世代の薬剤の開発にますます注目が集まっています。また、イオントフォアと合成抗コクシジウム剤を統合し、薬剤耐性を最小限に抑えながら寄生虫の駆除を最適化する併用療法へのシフトも進んでいます。

規制圧力は抗コクシジウム剤市場をどのように形成しているか？

畜産業における抗生物質や薬用飼料添加物の使用を規制する厳しい規制は、抗コクシジウム薬市場のダイナミクスに大きな影響を与えています。FDAや欧州医薬品庁（EMA）を含む政府や規制機関は、抗菌剤耐性（AMR）リスクを軽減するため、抗コクシジウム剤の使用に関する厳格なガイドラインを実施しています。このため、特定の伝統的な薬剤は段階的に使用されなくなり、製薬企業は代替の非抗菌性コクシジウム症対策ソリューションを開発する必要に迫られています。その結果、業界ではワクチンや植物性飼料添加物の採用が増加し、持続可能な家畜生産を確保しながら規制遵守に沿った新規抗コクシジウム製剤の需要が高まっています。

市場の進化において技術革新が果たす役割とは？

抗コクシジウム薬市場は、ドラッグの製剤化、デリバリー・メカニズム、精密畜産の進歩に伴い、技術的な変革期を迎えています。薬物動態や標的作用が改善された新薬分子が開発され、毒性リスクを低減しながら治療効果を高めています。ナノテクノロジーもまた、より優れた薬物吸収と徐放を可能にすることで、効能の長期化を実現しつつあります。さらに、疾病サーベイランスにおける人工知能（AI）とビッグデータ解析の統合により、農家はタイムリーで効果的なコクシジウム症管理戦略を実施するためのリアルタイムの知見を得ることができます。これらの技術革新は、薬剤の有効性を最適化するだけでなく、費用対効果が高く、環境的に持続可能な家畜の飼育方法にも貢献しています。

市場拡大を加速する主な成長促進要因は？世界の抗コクシジウム薬市場の成長は、高品質の動物性タンパク質に対する需要の高まり、家畜生産の増加、商業養鶏場の拡大など、いくつかの要因によって牽引されています。特に新興経済圏では、急速な都市化と食生活の嗜好の変化が、家畜の効果的な疾病対策の必要性をさらに高めています。さらに、動物用医薬品の進歩や新規製剤の導入により、治療の展望が広がっています。ワクチン接種、バイオセキュリティ、新規の飼料添加物を組み込んだ総合的なコクシジウム症管理へのシフトも、市場の成長を促進しています。さらに、次世代の抗コクシジウム剤を開発するための製薬会社と研究機関との戦略的提携は、今後数年間における業界の持続的な拡大を促進する見通しです。

セグメント

薬剤クラス別（合成薬剤、イオノフォア薬剤）、薬剤作用別（コクシジウム静菌作用、殺コクシジウム作用）、動物タイプ別（コンパニオンアニマル、家畜動物）、

調査対象企業の例

  • Biochem Pharmaceuticals
  • Boehringer Ingelheim Animal Health USA Inc.
  • Ceva Sante Animale
  • Elanco Animal Health Incorporated
  • HIPRA SA
  • Huvepharma
  • Impextraco NV
  • Merck & Co., Inc.-MSD Animal Health
  • Phibro Animal Health Corporation
  • Vetoquinol India Animal Health Pvt Ltd
  • VIRBAC Animal Health India Private Ltd.
  • Zoetis India Ltd

AI統合

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP29182

Global Anticoccidial Drugs Market to Reach US$254.6 Million by 2030

The global market for Anticoccidial Drugs estimated at US$203.1 Million in the year 2024, is expected to reach US$254.6 Million by 2030, growing at a CAGR of 3.8% over the analysis period 2024-2030. Synthetic Drugs, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$148.1 Million by the end of the analysis period. Growth in the Ionophore Drugs segment is estimated at 2.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$53.4 Million While China is Forecast to Grow at 3.8% CAGR

The Anticoccidial Drugs market in the U.S. is estimated at US$53.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$41.1 Million by the year 2030 trailing a CAGR of 3.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 3.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Global Anticoccidial Drugs Market - Key Trends & Drivers Summarized

What is Fueling the Demand for Anticoccidial Drugs Worldwide?

Coccidiosis remains a persistent threat to livestock, particularly in poultry and cattle, causing significant economic losses due to morbidity, mortality, and decreased productivity. The growing global demand for protein-rich foods, such as chicken and eggs, has heightened the need for effective anticoccidial drugs. Large-scale poultry farming operations rely heavily on prophylactic and therapeutic anticoccidials to maintain herd health and prevent outbreaks. Additionally, with emerging strains of Eimeria parasites displaying resistance to traditional treatments, there is an increasing focus on developing new-generation drugs with enhanced efficacy and reduced resistance profiles. The market is also experiencing a shift towards combination therapies that integrate ionophores and synthetic anticoccidials to optimize parasite control while minimizing drug resistance.

How is Regulatory Pressure Reshaping the Anticoccidial Market?

Stringent regulations governing the use of antibiotics and medicated feed additives in animal husbandry have significantly influenced the dynamics of the anticoccidial drugs market. Governments and regulatory agencies, including the FDA and the European Medicines Agency (EMA), are enforcing strict guidelines on the use of anticoccidials to mitigate antimicrobial resistance (AMR) risks. This has led to the phasing out of certain traditional drugs, compelling pharmaceutical companies to develop alternative, non-antibiotic coccidiosis control solutions. Consequently, the industry is witnessing an increased adoption of vaccines and phytogenic feed additives, alongside a rising demand for novel anticoccidial formulations that align with regulatory compliance while ensuring sustainable livestock production.

What Role Does Technological Innovation Play in Market Evolution?

The anticoccidial drugs market is undergoing a technological transformation with advancements in drug formulation, delivery mechanisms, and precision livestock farming. New drug molecules with improved pharmacokinetics and targeted action are being developed to enhance treatment outcomes while reducing toxicity risks. Nanotechnology is also gaining traction, enabling better drug absorption and sustained release for prolonged efficacy. Additionally, the integration of artificial intelligence (AI) and big data analytics in disease surveillance is empowering farmers with real-time insights to implement timely and effective coccidiosis management strategies. These innovations are not only optimizing drug efficacy but also contributing to cost-effective and environmentally sustainable livestock rearing practices.

What Are the Key Growth Drivers Accelerating the Market Expansion? The growth in the global anticoccidial drugs market is driven by several factors, including the rising demand for high-quality animal protein, increasing livestock production, and the expansion of commercial poultry farms. Rapid urbanization and evolving dietary preferences, particularly in emerging economies, are further amplifying the need for effective disease control measures in livestock. Additionally, advancements in veterinary pharmaceuticals and the introduction of novel drug formulations are expanding the treatment landscape. The shift towards integrated coccidiosis management, incorporating vaccination, biosecurity, and novel feed additives, is also fueling market growth. Furthermore, strategic collaborations between pharmaceutical companies and research institutions to develop next-generation anticoccidials are poised to drive sustained industry expansion in the coming years.

SCOPE OF STUDY:

The report analyzes the Anticoccidial Drugs market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Drug Class (Synthetic Drugs, Ionophore Drugs); Drug Action (Coccidiostatic Action, Coccidiocidal Action); Animal Type (Companion Animals, Livestock Animals);

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 36 Featured) -

  • Biochem Pharmaceuticals
  • Boehringer Ingelheim Animal Health USA Inc.
  • Ceva Sante Animale
  • Elanco Animal Health Incorporated
  • HIPRA SA
  • Huvepharma
  • Impextraco NV
  • Merck & Co., Inc. - MSD Animal Health
  • Phibro Animal Health Corporation
  • Vetoquinol India Animal Health Pvt Ltd
  • VIRBAC Animal Health India Private Ltd.
  • Zoetis India Ltd

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Anticoccidial Drugs - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Poultry and Livestock Disease Prevention Driving Market Growth
    • Expansion of Intensive Animal Farming Increasing the Need for Anticoccidial Agents
    • Rising Adoption of Ionophores and Non-Ionophore Anticoccidials in Feed Additives
    • Increasing Focus on Sustainable and Antibiotic-Free Coccidiosis Prevention
    • Surge in Development of Next-Generation Vaccines as Alternatives to Drugs
    • Expansion of Integrated Farm Management Practices Enhancing Drug Efficacy
    • Growing Investments in Herbal and Natural Anticoccidial Solutions
    • Increasing Demand for Combination Therapies for Enhanced Parasite Control
    • Advancements in Genomic Research for Targeted Coccidiosis Treatment
    • Rising Consumer Demand for Organic Meat Driving Shift Towards Natural Solutions
    • Expansion of Anticoccidial Drug Use in Companion Animals and Exotic Species
    • Growing Strategic Partnerships for Global Distribution of Anticoccidial Drugs
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Anticoccidial Drugs Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Anticoccidial Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Anticoccidial Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Synthetic Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Synthetic Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Ionophore Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Ionophore Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Coccidiostatic Action by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Coccidiostatic Action by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Coccidiocidal Action by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Coccidiocidal Action by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Companion Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Companion Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Livestock Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Livestock Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Anticoccidial Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 16: USA Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 17: USA 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
    • TABLE 18: USA Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 19: USA 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
  • CANADA
    • TABLE 22: Canada Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 23: Canada 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Canada 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
  • JAPAN
    • Anticoccidial Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Japan 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Japan 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
  • CHINA
    • Anticoccidial Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 34: China Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 35: China 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
    • TABLE 36: China Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 37: China 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
  • EUROPE
    • Anticoccidial Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 40: Europe Recent Past, Current & Future Analysis for Anticoccidial Drugs by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 41: Europe 6-Year Perspective for Anticoccidial Drugs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Europe 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
  • FRANCE
    • Anticoccidial Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 48: France Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 49: France 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
    • TABLE 50: France Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
    • TABLE 52: France Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 53: France 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
  • GERMANY
    • Anticoccidial Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 54: Germany Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Germany 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Germany 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
  • ITALY
    • TABLE 60: Italy Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Italy 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Italy 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
  • UNITED KINGDOM
    • Anticoccidial Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 66: UK Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 67: UK 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
    • TABLE 68: UK Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
    • TABLE 70: UK Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 71: UK 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 72: Rest of Europe Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Rest of Europe 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
    • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Rest of Europe 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Anticoccidial Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 78: Asia-Pacific Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Asia-Pacific 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
    • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Asia-Pacific 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 84: Rest of World Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of World 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
    • TABLE 86: Rest of World Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of World 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of World 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030

IV. COMPETITION